What is the price of Ripretinib?

Ripretinib can treat adult patients with gastrointestinal stromal tumors (GIST). Its original drug has been marketed in China and has been approved by the National Medical Insurance Bureau to enter the scope of Class B medical insurance. However, it is only available to patients who meet the indications. The price of each box of 50mg*30 tablets may be around 30,000 yuan. The expensive price may increase the pressure on families with heavy financial burdens. The US version of Ripetinib Specifications50mg*90 tablets sold overseas may be priced around RMB 77,000 per box (the price may fluctuate due to exchange rates). The ingredients of foreign original drugs are basically the same as those of domestic original drugs. Currently, there are no generic drugs of Ripetinib produced and marketed overseas.